Co-Producer
|
|
| June
5, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
WEEKLY CEO Q&A:
Robin Toft, CEO, Curebound |
|
In this Q&A, Robin talks about her
career pivot into the nonprofit sector,
the collaborative research model that sets
Curebound apart, the growing role of
philanthropic capital to fill funding
gaps, and what it takes to build both a
high-performing team and a research
accelerator with staying power. More |
|
|
|
|
Join
us September 30 – October 1 for
LSPA’s largest partnering event of
the year. Connect with the life
sciences ecosystem throughout the
Commonwealth and beyond, get the
latest information through timely
panel discussions and learn about
the newest innovations shaping the
industry.
|
|
Learn More
→ |
|
|
- BMS: Early Detection in Brazil is a Game
Changer for Lung Cancer Care More
- Made Scientific and Pluristyx: Launch
Integrated iPSC Development &
Manufacturing Partnership to Advance
Next-Generation iPSC-derived Cell Therapies More
- Otsuka: Presents Positive Interim Phase 3
VISIONARY eGFR Data Showing VOYXACT
(sibeprenlimab-szsi) Preserved Kidney
Function Over 12 Months in IgA Nephropathy
(IgAN) More
More*
More*
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- BioPharmCatalyst Weekly Watchlist: Countdown
to the End of the Quarter More
- Cancer R&D Partnerships, M&A,
Venture Funding and IPO Activity – Q1 2026
Review More
- LSN: Hot Investor Mandate (Updated 6/2) More
- Madrigal Pharmaceuticals: Grants of
Inducement Awards Under Nasdaq Listing Rule
5635(c)(4) More
- NRx Pharmaceuticals: Closing of $22.3
Million Public Offering of Common Stock and
Including Exercise of the Underwriters'
Option More
- Greater Philadelphia Rises Two Spots in
Top U.S. Biotech Clusters Ranking More*
More
- UroGen Pharma: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Big4Bio CEO Weekly Q&A: Robin Toft,
CEO, Curebound More
- BioPharmGuy News: Machine Wins, Cancer
Loses, Lizards Win, Eye Lose More
- From Business Strategy to CAR-T Responses,
for Cabaletta It's All About 'Durability' More
- Lilly Gateway Labs Incubator in Center City
Gets Its First Tenant More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The (r)Evolutionary STEMist With Joanna
Ghayad: How Cabaletta Bio is Leading the Race
for Autoimmune Cellular Therapies Video
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Telling Your Science Story to
Investors More
- AI in Biotech: The New
Frontier for Leadership & Strategy More
- David Chang to Hand Over the Reins at
Allogene; Ex-Esperion CEO Gets Started at
Phlow More*
- 11 Companies Hiring in New Jersey Now More
- Empowering Students Through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- Hiring Outlook: Job Opportunities on
BioSpace Rise YOY, but Layoffs Affect
Thousands More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- SJU: Path to Commercialization in Healthcare
- St Luke's University Health Network's Kira
Bub (Marketing & Public Relations) is
Interviewed by Giovanna Torchia & Jon Evoy
Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Philadelphia Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Philadelphia,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
